Back to OurEnergyLibrary search




Case Study: AstraZeneca and Vanguard Renewables U.S. RNG Agreement

Case Study: AstraZeneca and Vanguard Renewables U.S. RNG Agreement

Full Title: Case Study: AstraZeneca and Vanguard Renewables U.S. RNG Agreement
Author(s): Renewable Thermal Collaborative
Publisher(s): Renewable Thermal Collaborative
Publication Date: February 28, 2024
Full Text: Download Resource
Description (excerpt):

This case study details the groundbreaking renewable natural gas (RNG) agreement between RTC Member AstraZeneca, a global biopharmaceutical company, and RTC Solutions Provider Vanguard Renewables. It provides an in-depth look at one of the largest business-to-business RNG purchases in the North American voluntary market, which will supply AstraZeneca with 650,000 MMBtu/year for 15+ years and contribute to the company’s ambition to reduce greenhouse gas emissions from its global operations (Scope 1 and 2) by 98% by 2026. Vanguard Renewables will build three new on-farm anaerobic digesters to produce the RNG.

Read this case study to understand the project’s origins, the decision-making process, and the collaborative efforts that led to its success. The case study offers valuable insights for others seeking to decarbonize their operations with renewable thermal solutions, especially RNG.

All statements and/or propositions in discussion prompts are meant exclusively to stimulate discussion and do not represent the views of OurEnergyPolicy.org, its Partners, Topic Directors or Experts, nor of any individual or organization. Comments by and opinions of Expert participants are their own.

Sign up for our Press Release Distribution List

    Your Name (required)

    Your Email (required)

    Please sign me up to receive press releases from OurEnergyPolicy.org.